Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Online empathy training aims to ease teacher burnout in germany

NCT ID NCT06477250

Symptom relief Sponsor: Max Planck Social Neuroscience Lab Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a 10-week online program where teachers practice empathy and compassion with a partner. The goal is to reduce burnout, stress, and improve mental health and classroom climate. 200 teachers in Germany will participate, and researchers will measure changes using surveys, voice recordings, and heart rate monitors.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

200 people

The number who actually took part.

Started

Jun 2024

Expected to finish

Dec 2025

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Participation Criteria / Eligibility Criteria Ages Eligible for Study 18 Years to 65 Years (Adult, Older Adult) Sexes Eligible for Study All Accepts Healthy Volunteers Yes Inclusion Criteria: Participants will have to meet the following inclusion criteria: 1. between 18- and 65-years old 2. registered residents of Germany 3. currently employed as a teacher in Germany 4. proficient in the German language Exclusion Criteria: Participants would be excluded: 1. if they do not have access to the internet or technical equipment necessary. 2. if they have a history of or current psychiatric diagnosis. 3. Toronto Alexithymia Scale-20 (TAS-20; Bagby et al., 1994; Brähler et al., 2000; exclude if score greater than 60) 4. Patient Health Questionnaire-9 (PHQ-9; Gräfe et al., 2004; Löwe et al., 2004; exclude if scores greater than 19) low 2004 5. Generalized Anxiety Disorder-7 (GAD-7; Löwe et al., 2007; Spitzer et al., 2006; exclude if scores greater than 15) 6. if endorsing suicidality on the PHQ-9. 7. if endorsing personality disorder on the Standardized Assessment of Severity of Personality Disorder Questionnaire (SAPAS; Moran et al., 2003; Söchtig et al., 2012).

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Burnout are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Altruism Burnout, Psychological Psychological Well-Being

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Burnout

Contacts and locations

Locations

  • Social NeuroScience Lab, Max Planck, Berlin

    Berlin, 10557, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.